These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14516934)

  • 1. Polycystic ovary syndrome: syndrome XX?
    Sam S; Dunaif A
    Trends Endocrinol Metab; 2003 Oct; 14(8):365-70. PubMed ID: 14516934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in women with polycystic ovary syndrome.
    Dunaif A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S13-4. PubMed ID: 16798274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.
    Urbanek M; Sam S; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in the polycystic ovary syndrome.
    Dunaif A; Thomas A
    Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin action in the polycystic ovary syndrome.
    Dunaif A
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):341-59. PubMed ID: 10352922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
    Waterworth DM; Bennett ST; Gharani N; McCarthy MI; Hague S; Batty S; Conway GS; White D; Todd JA; Franks S; Williamson R
    Lancet; 1997 Apr; 349(9057):986-90. PubMed ID: 9100625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
    Dunaif A; Xia J; Book CB; Schenker E; Tang Z
    J Clin Invest; 1995 Aug; 96(2):801-10. PubMed ID: 7635975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in resistin gene promoter not associated with polycystic ovary syndrome.
    Urbanek M; Du Y; Silander K; Collins FS; Steppan CM; Strauss JF; Dunaif A; Spielman RS; Legro RS
    Diabetes; 2003 Jan; 52(1):214-7. PubMed ID: 12502516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
    Diamanti-Kandarakis E; Dunaif A
    Endocr Rev; 2012 Dec; 33(6):981-1030. PubMed ID: 23065822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in polycystic ovary syndrome: progress and paradoxes.
    Venkatesan AM; Dunaif A; Corbould A
    Recent Prog Horm Res; 2001; 56():295-308. PubMed ID: 11237218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.
    Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T
    Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.
    Wu XK; Zhou SY; Liu JX; Pöllänen P; Sallinen K; Mäkinen M; Erkkola R
    Fertil Steril; 2003 Oct; 80(4):954-65. PubMed ID: 14556818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
    Dunaif A
    Am J Med; 1995 Jan; 98(1A):33S-39S. PubMed ID: 7825639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
    Mukherjee S; Maitra A
    Indian J Med Res; 2010 Jun; 131():743-60. PubMed ID: 20571162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic beta-cells dysfunction in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Xyrafis X; Boutzios G; Christakou C
    Panminerva Med; 2008 Dec; 50(4):315-25. PubMed ID: 19078872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.